Quantcast
Glaukos Corp (NYSE: GKOS) | The Mesh Report

Glaukos Corp (NYSE: GKOS)

Christian Tharp, CMT November 6, 2018 Comments Off on Glaukos Corp (NYSE: GKOS)

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma.

Take a look at the 1-year chart of Glaukos (NYSE: GKOS) below with my added notations:

1-year chart of Glaukos (NYSE: GKOS)

GKOS has formed a down-channel over the past couple of months. A channel is simply formed through the combination of a trend line support that runs parallel to a trend line resistance.

When it comes to channels, remember that any (3) points can start the channel, but a 4th point or more confirms it. You can see that GKOS has tested its channel trendlines multiple times.

The Tale of the Tape: GKOS has formed a common pattern known as a channel, in this case a down channel. A long trade could be entered on a pullback down to the channel support, or on a break through the channel resistance. Short opportunities would be on rallies up to channel resistance or on a break of channel support.

Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.

No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!

Good luck!
Christian Tharp, CMT



Comments are closed.